Skip to main content
249 results:
31. Service Measurements  
Next to our Nexus IB10 automated and portable immunoassay system we also provide customized MTP assays and testing services to fulfill the specific requirements of our customers.  
32. SphingoTec appoints Jörg Menten as CEO to accelerate commercialization and global growth  
Jörg Menten, previously acting as Chief Commercial Officer of the company, will focus on successfully commercializing the biomarker-based diagnostics that address high unmet needs in critical care…  
33. Media Relations  
Media Relations page  
34. Distribution Partners  
SphingoTec has an international qualified network of distribution partners with which we work in close cooperation and mutual support. We are committed to providing our partners with exceptional…  
35. Biomarker-guided trial led by University Hospital Hamburg-Eppendorf (UKE) opens new avenues for personalized medicine in COVID-19  
The implementation of two critical care biomarkers guides the application of a potential new drug candidate for the treatment of COVID-19 patients.  
36. COVID-19  
In severely ill COVID-19 patients, besides the main complications that include respiratory, cardiovascular and kidney diseases, an emerging body of evidence shows that endothelial function plays a…  
37. The Biomarkers bio-ADM and DPP3 Complement Post-Cardiac Surgery Diagnostics to Early Detect Organ Failure  
New evidence supporting the use of innovative biomarkers in the early identification of organ dysfunction and risk stratification of cardiac surgery patients is reported.  
38. SphingoTec and Rivaara Labs Close Exclusive Distribution Agreement for Point of Care Diagnostics in India  
SphingoTec and Rivaara Labs today announced that they have entered into a multi-year distribution agreement for the commercialization of SphingoTec’s point of care diagnostic solutions in the Indian…  
39. Proenkephalin (penKid) sheds light on the diagnostic blind spots in assessing acute kidney injury in children  
SphingoTec announces that its kidney function biomarker penKid is reliably identifying AKI in infants, offering a solution to the shortcomings in pediatric critical care. AKI is mostly diagnosed too…  
Follow our Journey on Social Media View all Events View all News Events & Expos Latest News Subscribe to our Newsletter Follow the link below to subscribe to our…  
Search results 31 until 40 of 249